2018 Czech Republic Molecular Diagnostic Analyzers and Reagents: Molecular Diagnostic Analyzers and Reagents: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review

March 2018 | 1120 pages | ID: 28F1D79298BEN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

• Five-year test volume and sales forecasts
• Feature comparison of major analyzers
• Profiles of market players and start-up firms developing innovative technologies and products
• Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

• Five-year test volume and sales forecasts for major applications, including:
• Infectious Diseases - Forensic Testing
• Cancer - Paternity Testing/HLA Typing
• Genetic Diseases - Others
• Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

• Comparison of leading molecular diagnostic analyzers.
• Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
• PCR - bDNA
• SDA - NASBA
• TMA - SSSR, and others
• LCR
• Companies, universities and research centers developing new molecular-diagnostic technologies and products.

Competitive Assessments

Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations

• New product development opportunities with potentially significant market appeal during the next five years.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Contents

1. INTRODUCTION

2. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

3. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

4. ALTERNATIVE MARKET PENETRATION STRATEGIES

5. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

6. MOLECULAR DIAGNOSTIC TECHNOLOGY REVIEW

A. DNA Sequencing
B. DNA and RNA Probe Technologies
C. Detection Technologies
D. Biochips: Genosensors, Microarrays, and Labs on    the Chip
E. Pharmacogenomics
F. Competing/complementing
  1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
  2. RNA PROBES
  3. TWO DIMENSIONAL ELECTROPHORESIS
  4. FLOW CYTOMETRY

7. MOLECULAR DIAGNOSTIC INSTRUMENTATION REVIEW

8. MAJOR APPLICATIONS

  1. MICROBIOLOGY/INFECTIOUS DISEASES
    a. Overview
    b. Major Infectious Diseases
  AIDS/HIV

  Adenovirus
  Aeromonads
  Anthrax/Bacillus Anthracis
  Arboviruses
  Babesiosis
  Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
  Blastocystis Hominis
  Brucella
  Campylobacter
  Candida
  Chagas Disease
  Chancroid
  Chlamydia
  Clostridium Difficile
  Coronaviruses
  Coxsackieviruses
  Creutzfeldt Jakob’s Disease
  Cryptosporidium Parvum
  Cyclospora Cayetanensis
  Cytomegalovirus
  Ebola Virus
  E. Coli
  Echovirus
  Encephalitis
  Enteroviruses
  Epstein    Barr Virus
  Giardia Lamblia
  Gonorrhea
  Granuloma Inguinale
  Hantavirus
  Helicobacter Pylori
  Hepatitis
  Herpes Simplex Virus
  Human Herpes Virus 6 (HHV    6)
  Influenza Viruses
  Legionella
  Lyme Disease
  Lymphogranuloma Venereum (LGV)
  Malaria
  Measles (Rubeola)
  Meningitis
  Microsporidium
  Mononucleosis
  Mumps
  Mycoplasma
  Papillomaviruses
  Parvovirus B19
  Pneumonia
  Polyomaviruses
  Pseudomonas Aeruginosa
  Rabies
  Respiratory Syncytial Virus (RSV)
  Rhinoviruses
  Rotavirus
  Rubella
  Salmonellosis
  Septicemia
  Shigellosis
  Staphylococcus Aureus
  Streptococci
  Syphilis
  Toxoplasmosis
  Trichomonas Vaginalis
  Tuberculosis
  Vibrio
  West Nile Virus
  Yersinia
  2. CANCER TESTING
    a. Overview
    b. Major Cancer Types
  Prostate
  Lung
  Colon and Rectum
  Breast
  Skin
  Uterine
  Leukemia
  Oral
    c. Oncogenes
  Abl/abl bcr
  AIB1
  BCL2
  BRCA1
  CD44
  C-fos
  C-myb
  C-myc
  CYP17
  ErbB
  HPC1
  Nmyc
  P40
  P51
  P53
  PIK3CA
  PTI1
  Ras
  Reg
  Sis
  Src
  3. GENETIC DISEASES
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
  Achondroplasia
  Autosomal Dominant Polycystic Kidney Disease
  Cancer
  Cosmetogenomics
  Cystic Fibrosis
  Down's Syndrome
  Duchenne and Becker Muscular Dystrophy
  Factor V (Leiden)
  Factor IX Deficiency
  Fragile X Syndrome
  Heart Disease
  Hemochomatosis
  Hemophilia
  Huntington's Disease
  Maternal Fetal Incompatibility
  Multiple Endocrine Neoplasia
  Phenylketonuria (PKU)
  Polycystic Kidney Disease (PKD)
  Prenatal Screening
  Retinitis Pigmentosa
  Retinoblastoma
  Sickle Cell Anemia
  Spinal Muscular Atrophy
  Vitamin B12 Metabolism
    i. Social Issues and Concerns
  4. FORENSIC TESTING
    a. Overview
    b. Multilocus and Single Locus Probes
  Multilocus Probes
  Single Locus Probes
  PCR and RFLP
    c. DNA Profile Data Banks
    d. Judicial Implementation
    e. Major Crime Categories
    f. Factors Contributing to the DNA Probe Market Expansion
  Technology Availability
  Use of Hair as Evidence
    g. Wildlife Forensics
  5. PATERNITY TESTING/HLA TYPING
  6. OTHER APPLICATIONS
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other

9. MARKET SIZE AND GROWTH: TEST VOLUME AND SALES FORECASTS

10. COMPETITIVE ASSESSMENTS

  Abbott
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  bioMerieux
  Bio-Rad
  Biotest
  CellMark Forensics/LabCorp
  Cepheid
  Decode Genetics
  Diadexus
  Eiken
  Elitech Group
  Enzo
  Exact Sciences
  Fujirebio
  Grifols
  Hologic/Genrobe
  Illumina
  Kreatech/Leica
  Li Cor Biosciences
  Monogram Biosciences/LabCorp
  Myriad Genetics
  Ortho    Clinical Diagnostics
  Perkin Elmer/Caliper
  Proteome Sciences
  Qiagen
  Roche
  Scienion
  Sequenom
  Shimadzu
  Siemens
  Sierra Molecular
  Takara Bio
  Tecan Group
  Thermo Fisher/Affymetrix

11. APPENDIX: RESEARCH CENTERS DEVELOPING NEW TECHNOLOGIES AND PRODUCTS

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume and Sales Forecasts by Major Application Molecular Diagnostics Test Volume by Major Application Major Infectious Disease Test Volume by Assay Major Infectious Disease Test Volume by Method Molecular Diagnostics Market by Major Application Major Infectious Disease Diagnostics Market by Assay
Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases